Home LiteratureArticle Details
PMID: 1717618 Published · ppublish English Journal Article Review

Tumor necrosis factor and immunopathology.

Immunologic research ·Vol. 10 ·No. 2 ·1991-00-00 ·Pages 122-40

Piguet PF, Grau GE, Vassalli P

Abstract

暂无摘要

MeSH Terms
Autoimmune Diseases/immunology Bleomycin/adverse effects Collagen Diseases/immunology,physiopathology Cytotoxicity, Immunologic Dermatitis, Contact/immunology,physiopathology Graft vs Host Disease/immunology Immunity, Cellular Interferon-gamma/physiology Interleukins/physiology Malaria/immunology Mast Cells/immunology Mycobacterium Infections/immunology Silicosis/immunology Tumor Necrosis Factor-alpha/immunology,metabolism,physiology
Chemicals
Interleukins Tumor Necrosis Factor-alpha Bleomycin Interferon-gamma
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Piguet P F
Department of Pathology, University of Geneva, CMU, Switzerland.
Grau G E
Vassalli P
References (101)
101 references, click to expand
  1. Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma.
    Eur J Immunol. 1987 Dec;17(12):1855-8 PMID: 3121361
  2. Heterogeneous effects of IFN-gamma in adjuvant arthritis.
    J Immunol. 1989 Mar 1;142(5):1500-5 PMID: 2493048
  3. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.
    Immunol Rev. 1989 Dec;112:49-70 PMID: 2575074
  4. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice.
    Lab Invest. 1976 Dec;35(6):558-68 PMID: 62893
  5. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected].
    N Engl J Med. 1989 May 25;320(21):1420-1 PMID: 2785642
  6. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease.
    Transplantation. 1989 Jan;47(1):50-4 PMID: 2643231
  7. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.
    Proc Natl Acad Sci U S A. 1990 Feb;87(3):968-72 PMID: 2405400
  8. Origin and nature of the cells participating in the popliteal graft versus host reaction in mouse and rat.
    Cell Immunol. 1977 Jun 15;31(2):242-54 PMID: 17470
  9. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
    J Exp Med. 1985 Dec 1;162(6):2163-8 PMID: 2999289
  10. Histologic studies on the hepatic lesions induced by graft-versus-host reaction in MHC class II disparate hosts compared with primary biliary cirrhosis.
    Am J Pathol. 1989 Aug;135(2):301-7 PMID: 2782375
  11. Effect of tumor necrosis factor alpha on mitogen-activated human B cells.
    J Exp Med. 1987 Sep 1;166(3):786-91 PMID: 3040886
  12. Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells.
    Eur J Immunol. 1986 Oct;16(10):1257-61 PMID: 3490387
  13. Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase.
    J Immunol. 1990 Feb 15;144(4):1304-10 PMID: 2137489
  14. Cyclosporine A inhibits TNF production without decreasing TNF mRNA levels.
    Biochem Biophys Res Commun. 1989 Jun 15;161(2):551-5 PMID: 2735909
  15. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro.
    Ann Neurol. 1988 Apr;23(4):339-46 PMID: 3132891
  16. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.
    Nature. 1988 Jan 28;331(6154):356-8 PMID: 2893286
  17. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.
    Cell. 1989 Mar 10;56(5):731-40 PMID: 2647299
  18. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.
    Science. 1986 May 23;232(4753):977-80 PMID: 3754653
  19. Tumor necrosis factor identified in multiple sclerosis brain.
    J Exp Med. 1989 Aug 1;170(2):607-12 PMID: 2754393
  20. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta.
    Science. 1989 Mar 17;243(4897):1467-9 PMID: 2648570
  21. Tumor necrosis, cachexia, shock, and inflammation: a common mediator.
    Annu Rev Biochem. 1988;57:505-18 PMID: 3052281
  22. In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function.
    J Invest Dermatol. 1987 Apr;88(4):380-7 PMID: 3104480
  23. A mouse monoclonal IgE antibody anti bovine milk beta-lactoglobulin allows studies of allergy in the gastrointestinal tract.
    Clin Exp Immunol. 1986 Mar;63(3):703-10 PMID: 3708909
  24. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.
    Nature. 1986 Sep 4-10;323(6083):86-9 PMID: 3092113
  25. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis.
    J Clin Invest. 1989 Oct;84(4):1253-9 PMID: 2794062
  26. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.
    J Exp Med. 1986 Dec 1;164(6):2113-8 PMID: 3097240
  27. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis.
    Am J Pathol. 1990 Jan;136(1):103-10 PMID: 1688687
  28. Graft-versus-host disease.
    Immunol Rev. 1985 Dec;88:193-214 PMID: 3910557
  29. Human and murine cutaneous graft-versus-host diseases. Potential models for the study of immunologically mediated skin diseases.
    Br J Dermatol. 1984 Jul;111 Suppl 27:213-8 PMID: 6234923
  30. Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.
    Am J Pathol. 1987 Sep;128(3):410-25 PMID: 3115109
  31. Macrophages, dust, and pulmonary diseases.
    Exp Lung Res. 1987;12(2):89-107 PMID: 3552644
  32. Cytokines in skin lesions of psoriasis.
    Cytokine. 1990 Jan;2(1):68-75 PMID: 2104215
  33. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1989 Jul;86(14):5572-4 PMID: 2501793
  34. Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung.
    Am J Pathol. 1979 Aug;96(2):531-44 PMID: 89815
  35. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9175-9 PMID: 3321069
  36. A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain.
    J Exp Med. 1990 Jun 1;171(6):2141-6 PMID: 2351934
  37. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.
    J Exp Med. 1987 Jul 1;166(1):235-45 PMID: 3598461
  38. GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
    J Immunol. 1985 Sep;135(3):1637-43 PMID: 2410497
  39. Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo.
    Immunology. 1989 Aug;67(4):514-9 PMID: 2788610
  40. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.
    Science. 1985 Nov 22;230(4728):943-5 PMID: 3933111
  41. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.
    J Exp Med. 1987 Jun 1;165(6):1581-94 PMID: 3108447
  42. Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction.
    Immunology. 1989 Sep;68(1):18-23 PMID: 2509325
  43. Epidermal lesions of the GVHR: evaluation of the role of different MHC and non MHC loci and of the Ly-2+ and L3T4+ T lymphocytes.
    J Immunol. 1987 Jul 15;139(2):406-10 PMID: 2955041
  44. Role for T lymphocytes in silica-induced pulmonary inflammation.
    Lab Invest. 1989 Jul;61(1):46-52 PMID: 2545972
  45. The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.
    J Immunol. 1988 Jul 15;141(2):499-503 PMID: 2968403
  46. Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers.
    Am J Pathol. 1979 Jul;96(1):121-42 PMID: 37739
  47. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
    J Immunol. 1988 Nov 1;141(9):3050-4 PMID: 3262676
  48. Effect of murine gamma interferon on the cellular responses to bleomycin in mice.
    Exp Lung Res. 1988;14(5):687-704 PMID: 2465144
  49. Tumor necrosis factor and disease severity in children with falciparum malaria.
    N Engl J Med. 1989 Jun 15;320(24):1586-91 PMID: 2657427
  50. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.
    J Exp Med. 1978 Dec 1;148(6):1687-98 PMID: 363972
  51. Purification and physico-chemical characterization of rabbit tumor necrosis factor.
    J Immunol. 1980 Oct;125(4):1671-7 PMID: 6997383
  52. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response.
    Lab Invest. 1989 Dec;61(6):588-602 PMID: 2481148
  53. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus.
    Arthritis Rheum. 1989 Feb;32(2):146-50 PMID: 2920050
  54. Effects of recombinant murine tumor necrosis factor-alpha on immune function.
    J Immunol. 1990 Mar 1;144(5):1753-8 PMID: 2307839
  55. Endothelial-cell injury in cutaneous acute graft-versus-host disease.
    Am J Pathol. 1989 Dec;135(6):1097-103 PMID: 2596572
  56. Unraveling pulmonary fibrosis: the bleomycin model.
    Lab Invest. 1984 May;50(5):487-8 PMID: 6201673
  57. Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation.
    J Exp Med. 1988 Oct 1;168(4):1499-504 PMID: 3049913
  58. Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon.
    Biochem Biophys Res Commun. 1984 Aug 30;123(1):365-72 PMID: 6433919
  59. Prevention of murine cerebral malaria by low-dose cyclosporin A.
    Immunology. 1987 Aug;61(4):521-5 PMID: 3327806
  60. Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha.
    Transplantation. 1989 Jun;47(6):1057-61 PMID: 2525289
  61. Synergistic stimulation of macrophage proliferation by the monokines tumor necrosis factor-alpha and colony-stimulating factor 1.
    Blood. 1989 Jan;73(1):307-11 PMID: 2535945
  62. The leukocyte integrins.
    Adv Immunol. 1989;46:149-82 PMID: 2551146
  63. Collagen autoimmunity and arthritis.
    FASEB J. 1988 Nov;2(14):2950-6 PMID: 3053308
  64. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
    Lab Invest. 1987 Mar;56(3):234-48 PMID: 3029503
  65. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.
    Nature. 1990 Mar 15;344(6263):245-7 PMID: 2156165
  66. Cytotoxicity of tumor necrosis factor-alpha for human umbilical vein endothelial cells.
    Lab Invest. 1989 Jul;61(1):62-8 PMID: 2747218
  67. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.
    Infect Immun. 1988 Oct;56(10):2563-9 PMID: 3138177
  68. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor.
    J Immunol. 1990 Jan 1;144(1):129-35 PMID: 2104886
  69. Characteristics of tumor necrosis factor production in rheumatoid arthritis.
    Cell Immunol. 1989 Aug;122(1):131-45 PMID: 2473844
  70. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
    J Exp Med. 1989 Sep 1;170(3):655-63 PMID: 2475571
  71. HLA and disease 1982--a survey.
    Immunol Rev. 1983;70:193-218 PMID: 6339368
  72. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.
    Science. 1987 Sep 4;237(4819):1210-2 PMID: 3306918
  73. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice.
    J Clin Invest. 1989 Oct;84(4):1345-8 PMID: 2794065
  74. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients.
    J Exp Med. 1988 May 1;167(5):1743-8 PMID: 3367098
  75. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
    J Exp Med. 1985 Nov 1;162(5):1512-30 PMID: 3932579
  76. Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.
    J Exp Med. 1988 Apr 1;167(4):1472-8 PMID: 3282023
  77. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  78. Interleukin-1 and its biologically related cytokines.
    Adv Immunol. 1989;44:153-205 PMID: 2466396
  79. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha.
    J Immunol. 1988 Jan 15;140(2):531-6 PMID: 3257243
  80. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.
    J Immunol. 1989 Dec 1;143(11):3470-5 PMID: 2584702
  81. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.
    J Immunol. 1986 Oct 1;137(7):2348-54 PMID: 3093572
  82. Acute in vivo effects of human recombinant tumor necrosis factor.
    Lab Invest. 1987 Jun;56(6):583-90 PMID: 3599906
  83. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation.
    Am Rev Respir Dis. 1983 May;127(5):614-7 PMID: 6189434
  84. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis.
    Lab Invest. 1989 Jul;61(1):37-45 PMID: 2747216
  85. Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription.
    J Immunol. 1987 Aug 1;139(3):949-55 PMID: 3110291
  86. Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation.
    J Biol Response Mod. 1989 Dec;8(6):644-55 PMID: 2600604
  87. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
    J Exp Med. 1987 Nov 1;166(5):1280-9 PMID: 3316469
  88. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.
    Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233-7 PMID: 2105500
  89. Amelioration of acute graft vs host disease due to minor histocompatibility antigens by in vivo administration of anti-interleukin 2 receptor antibody.
    J Immunol. 1986 Sep 15;137(6):1874-7 PMID: 3091692
  90. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.
    J Immunol. 1988 Mar 1;140(5):1506-10 PMID: 3126227
  91. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
    J Immunol. 1987 Mar 15;138(6):1786-90 PMID: 3029221
  92. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells.
    EMBO J. 1987 Aug;6(8):2261-5 PMID: 3499313
  93. Cytokines and infection.
    Curr Opin Immunol. 1989-1990 Feb;2(3):380-4 PMID: 2534503
  94. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients.
    Transplantation. 1989 Apr;47(4):606-8 PMID: 2523100
  95. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.
    J Clin Invest. 1989 Dec;84(6):1873-82 PMID: 2531759
  96. Enhancement of in vivo immune response by tumor necrosis factor.
    J Immunol. 1987 Dec 1;139(11):3676-9 PMID: 3500228
  97. Graft-versus-host disease: an alternative hypothesis.
    Immunol Today. 1989 Nov;10(11):362-4 PMID: 2692593
  98. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression.
    Lab Invest. 1989 Jun;60(6):766-71 PMID: 2733382
  99. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
    J Exp Med. 1988 Mar 1;167(3):1211-27 PMID: 3351436
  100. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  101. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
Article Info
Journal
Immunologic research
Abbr.
Immunol Res
ISSN
0257-277X
DOI
10.1007/BF02918160
Published
1991-00-00
Pages
122-40
Language
English
Region
United States
NLM ID
8611087
Subset
IM
External Links
PubMed source DOI: 10.1007/BF02918160 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2